Can a stroke be considered cryptogenic in a patient with a patent foramen ovale who is wearing a rhythm monitor but has no documented atrial fibrillation?

Can This Stroke Be Called Cryptogenic?

Yes, you can still call it cryptogenic while the patient is wearing a monitor, but this is a provisional designation that requires completion of the cardiac monitoring workup before making definitive treatment decisions, particularly regarding PFO closure.

Understanding the Definition

The term "cryptogenic stroke" applies when an extensive workup for other aetiologies of stroke is negative 1. The key issue here is that your workup is not yet complete—the patient is actively wearing a rhythm monitor to rule out atrial fibrillation (AF).

The Critical Distinction

• Cryptogenic stroke means no identified cause after thorough evaluation
• PFO-associated stroke is a subset where PFO is deemed the likely culprit after excluding other causes, particularly AF 2, 3
• The presence of PFO alone does NOT make it PFO-associated stroke—you must rule out competing etiologies first

Why AF Detection Matters Before Labeling It Cryptogenic

The relationship between PFO and AF is inverse and clinically crucial: patients with PFO actually have a significantly lower risk of having AF compared to those without PFO (RR 0.52,95% CI 0.41-0.63) 4. This creates a diagnostic dilemma:

• If AF is found, the stroke is no longer cryptogenic—it's cardioembolic from AF, and the PFO becomes incidental 2
• The treatment paradigm completely changes: anticoagulation for AF versus PFO closure consideration
• PFO closure trials specifically excluded patients with AF and only showed benefit in truly cryptogenic (nonlacunar) strokes 2

The Practical Algorithm

Current Status: Provisionally Cryptogenic

You can use this term temporarily while stating:

• "Cryptogenic stroke, pending completion of cardiac rhythm monitoring"
• "Ischemic stroke of undetermined source with PFO, evaluation in progress"

What You Must Complete Before Finalizing

1. Adequate cardiac monitoring duration: Extended monitoring (30+ days) significantly increases AF detection rates 5, 3
2. Risk stratification for AF detection using:
   • Age (older patients more likely to have AF) 6, 4
   • CHA₂DS₂-VASc score
   • Left atrial size
   • Elevated BNP/NT-proBNP
   • Frequent PACs, prolonged PR interval 5

The Decision Point

Once monitoring is complete:

• If AF detected: Stroke is cardioembolic, not cryptogenic. Treat with anticoagulation. PFO is incidental.
• If no AF detected: Can definitively call it cryptogenic and proceed with PFO-associated stroke evaluation using RoPE score or PASCAL classification 2, 3

Critical Pitfall to Avoid

Do not proceed with PFO closure decisions until cardiac monitoring is complete 5, 3. The 2021 AHA/ASA guidelines explicitly state that PFO closure recommendations should be made only after determining "there is no alternative cause of the stroke" 2. Closing a PFO when undetected AF is the actual culprit would be both ineffective and potentially harmful, as it delays appropriate anticoagulation.

Special Consideration for This Patient

The fact that PFO patients have lower rates of AF detection (21.4% vs 42.7% in non-PFO patients) 6 actually works in your favor—the presence of PFO makes it less likely that prolonged monitoring will reveal AF. However, this statistical reality does not eliminate the need to complete the workup, especially if the patient has other AF risk factors (age ≥60, hypertension, diabetes, left atrial enlargement) 2, 5.

Bottom line: Use "cryptogenic" provisionally now, but emphasize that definitive classification and treatment decisions await completion of cardiac monitoring. The guidelines are clear that PFO closure is only indicated when the stroke is truly cryptogenic after extensive workup is negative 1, 2.